Clearline Capital LP bought a new stake in shares of Surgery Partners Inc (NASDAQ:SGRY) during the fourth quarter, HoldingsChannel.com reports. The fund bought 31,800 shares of the company’s stock, valued at approximately $385,000.
Several other large investors have also made changes to their positions in SGRY. Citadel Advisors LLC purchased a new position in shares of Surgery Partners during the 3rd quarter valued at approximately $129,000. BlueCrest Capital Management Ltd purchased a new position in shares of Surgery Partners during the 4th quarter valued at approximately $157,000. Aperio Group LLC purchased a new position in shares of Surgery Partners during the 4th quarter valued at approximately $173,000. Sterling Capital Management LLC purchased a new position in shares of Surgery Partners during the 3rd quarter valued at approximately $210,000. Finally, Voya Investment Management LLC purchased a new position in shares of Surgery Partners during the 2nd quarter valued at approximately $222,000.
Surgery Partners Inc (NASDAQ SGRY) opened at $17.25 on Tuesday. Surgery Partners Inc has a 52 week low of $7.10 and a 52 week high of $24.05. The company has a quick ratio of 1.92, a current ratio of 2.09 and a debt-to-equity ratio of 1.56. The company has a market capitalization of $841.27 and a price-to-earnings ratio of -57.50.
Surgery Partners declared that its board has approved a stock buyback plan on Friday, December 15th that permits the company to repurchase $50.00 million in shares. This repurchase authorization permits the company to purchase shares of its stock through open market purchases. Shares repurchase plans are generally an indication that the company’s board believes its shares are undervalued.
A number of brokerages have recently issued reports on SGRY. ValuEngine lowered Surgery Partners from a “hold” rating to a “sell” rating in a research report on Friday, February 2nd. Zacks Investment Research lowered Surgery Partners from a “hold” rating to a “sell” rating in a research report on Tuesday, February 6th. Benchmark set a $19.00 target price on Surgery Partners and gave the company a “buy” rating in a research report on Tuesday, January 30th. BidaskClub upgraded Surgery Partners from a “sell” rating to a “hold” rating in a research report on Wednesday, December 27th. Finally, Jefferies Group set a $18.00 target price on Surgery Partners and gave the company a “buy” rating in a research report on Thursday, March 1st. Three equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the stock. Surgery Partners presently has an average rating of “Hold” and an average target price of $18.57.
COPYRIGHT VIOLATION WARNING: “Clearline Capital LP Takes Position in Surgery Partners Inc (SGRY)” was first posted by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this story can be read at https://sportsperspectives.com/2018/03/13/clearline-capital-lp-takes-position-in-surgery-partners-inc-sgry.html.
Surgery Partners Company Profile
Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.
Want to see what other hedge funds are holding SGRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Surgery Partners Inc (NASDAQ:SGRY).
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.